nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—PGR—blood vessel—colon cancer	0.014	0.126	CbGeAlD
Etonogestrel—ESR1—blood vessel—colon cancer	0.011	0.0982	CbGeAlD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—AXIN2—colon cancer	0.00833	0.0439	CbGpPWpGaD
Etonogestrel—PGR—Ovarian Infertility Genes—MLH1—colon cancer	0.00803	0.0423	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptors—HNF4A—colon cancer	0.00745	0.0392	CbGpPWpGaD
Etonogestrel—PGR—epithelium—colon cancer	0.00684	0.0611	CbGeAlD
Etonogestrel—PGR—smooth muscle tissue—colon cancer	0.00659	0.0589	CbGeAlD
Etonogestrel—ESR1—embryo—colon cancer	0.00655	0.0586	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—SRC—colon cancer	0.00596	0.0314	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00589	0.031	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.00565	0.0298	CbGpPWpGaD
Etonogestrel—ESR1—epithelium—colon cancer	0.00535	0.0478	CbGeAlD
Etonogestrel—SHBG—bone marrow—colon cancer	0.00532	0.0476	CbGeAlD
Etonogestrel—PGR—lymphoid tissue—colon cancer	0.00527	0.0471	CbGeAlD
Etonogestrel—ESR1—smooth muscle tissue—colon cancer	0.00515	0.0461	CbGeAlD
Etonogestrel—SHBG—vagina—colon cancer	0.0051	0.0456	CbGeAlD
Etonogestrel—ESR1—renal system—colon cancer	0.00496	0.0443	CbGeAlD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—AXIN2—colon cancer	0.00489	0.0258	CbGpPWpGaD
Etonogestrel—PGR—vagina—colon cancer	0.00459	0.0411	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—PIK3CA—colon cancer	0.00453	0.0239	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptors—HNF4A—colon cancer	0.00437	0.023	CbGpPWpGaD
Etonogestrel—SHBG—liver—colon cancer	0.0043	0.0384	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—colon cancer	0.00419	0.0221	CbGpPWpGaD
Etonogestrel—ESR1—lymphoid tissue—colon cancer	0.00412	0.0368	CbGeAlD
Etonogestrel—ESR1—digestive system—colon cancer	0.00407	0.0364	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—AKT1—colon cancer	0.0037	0.0195	CbGpPWpGaD
Etonogestrel—ESR1—vagina—colon cancer	0.00359	0.0321	CbGeAlD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00345	0.0182	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00342	0.018	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptors—PPARG—colon cancer	0.00323	0.017	CbGpPWpGaD
Etonogestrel—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00309	0.0163	CbGpPWpGaD
Etonogestrel—ESR1—liver—colon cancer	0.00303	0.0271	CbGeAlD
Etonogestrel—PGR—lymph node—colon cancer	0.00297	0.0266	CbGeAlD
Etonogestrel—CYP3A4—renal system—colon cancer	0.00277	0.0247	CbGeAlD
Etonogestrel—ESR1—Estrogen signaling pathway—BRAF—colon cancer	0.00276	0.0146	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00256	0.0135	CbGpPWpGaD
Etonogestrel—Vaginal inflammation—Methotrexate—colon cancer	0.00241	0.00345	CcSEcCtD
Etonogestrel—Connective tissue disorder—Irinotecan—colon cancer	0.00239	0.00342	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.00239	0.0126	CbGpPWpGaD
Etonogestrel—Cystitis noninfective—Methotrexate—colon cancer	0.00236	0.00337	CcSEcCtD
Etonogestrel—Pain in extremity—Capecitabine—colon cancer	0.00235	0.00337	CcSEcCtD
Etonogestrel—Visual impairment—Irinotecan—colon cancer	0.00234	0.00335	CcSEcCtD
Etonogestrel—Haemoglobin—Fluorouracil—colon cancer	0.00234	0.00335	CcSEcCtD
Etonogestrel—Rhinitis—Fluorouracil—colon cancer	0.00233	0.00334	CcSEcCtD
Etonogestrel—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00233	0.00334	CcSEcCtD
Etonogestrel—Cystitis—Methotrexate—colon cancer	0.00233	0.00333	CcSEcCtD
Etonogestrel—Haemorrhage—Fluorouracil—colon cancer	0.00233	0.00333	CcSEcCtD
Etonogestrel—ESR1—lymph node—colon cancer	0.00232	0.0208	CbGeAlD
Etonogestrel—Hypoaesthesia—Fluorouracil—colon cancer	0.00232	0.00332	CcSEcCtD
Etonogestrel—Migraine—Capecitabine—colon cancer	0.00231	0.00331	CcSEcCtD
Etonogestrel—Pharyngitis—Fluorouracil—colon cancer	0.00231	0.00331	CcSEcCtD
Etonogestrel—Vaginal infection—Methotrexate—colon cancer	0.00228	0.00326	CcSEcCtD
Etonogestrel—CYP3A4—digestive system—colon cancer	0.00227	0.0203	CbGeAlD
Etonogestrel—Angiopathy—Vincristine—colon cancer	0.00226	0.00324	CcSEcCtD
Etonogestrel—Irritability—Capecitabine—colon cancer	0.00224	0.00321	CcSEcCtD
Etonogestrel—Mood swings—Capecitabine—colon cancer	0.00223	0.00319	CcSEcCtD
Etonogestrel—Alopecia—Vincristine—colon cancer	0.0022	0.00316	CcSEcCtD
Etonogestrel—Angiopathy—Irinotecan—colon cancer	0.0022	0.00316	CcSEcCtD
Etonogestrel—Immune system disorder—Irinotecan—colon cancer	0.00219	0.00314	CcSEcCtD
Etonogestrel—Mental disorder—Vincristine—colon cancer	0.00219	0.00313	CcSEcCtD
Etonogestrel—Bladder pain—Methotrexate—colon cancer	0.00218	0.00312	CcSEcCtD
Etonogestrel—Neoplasm—Methotrexate—colon cancer	0.00218	0.00312	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.00216	0.0114	CbGpPWpGaD
Etonogestrel—Alopecia—Irinotecan—colon cancer	0.00215	0.00308	CcSEcCtD
Etonogestrel—Breast disorder—Capecitabine—colon cancer	0.00212	0.00304	CcSEcCtD
Etonogestrel—Back pain—Vincristine—colon cancer	0.0021	0.00301	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00209	0.011	CbGpPWpGaD
Etonogestrel—Flatulence—Irinotecan—colon cancer	0.00208	0.00299	CcSEcCtD
Etonogestrel—Gastritis—Capecitabine—colon cancer	0.00208	0.00298	CcSEcCtD
Etonogestrel—Alopecia—Fluorouracil—colon cancer	0.00206	0.00295	CcSEcCtD
Etonogestrel—Back pain—Irinotecan—colon cancer	0.00205	0.00293	CcSEcCtD
Etonogestrel—Abdominal distension—Capecitabine—colon cancer	0.00205	0.00293	CcSEcCtD
Etonogestrel—Muscle spasms—Irinotecan—colon cancer	0.00203	0.00291	CcSEcCtD
Etonogestrel—Asthma—Capecitabine—colon cancer	0.00203	0.00291	CcSEcCtD
Etonogestrel—Erythema—Fluorouracil—colon cancer	0.00203	0.0029	CcSEcCtD
Etonogestrel—Ill-defined disorder—Irinotecan—colon cancer	0.00196	0.00281	CcSEcCtD
Etonogestrel—Bronchitis—Capecitabine—colon cancer	0.00195	0.0028	CcSEcCtD
Etonogestrel—Malaise—Irinotecan—colon cancer	0.00191	0.00273	CcSEcCtD
Etonogestrel—Dysuria—Capecitabine—colon cancer	0.0019	0.00272	CcSEcCtD
Etonogestrel—ESR1—Nuclear Receptors—PPARG—colon cancer	0.0019	0.01	CbGpPWpGaD
Etonogestrel—Upper respiratory tract infection—Capecitabine—colon cancer	0.00189	0.0027	CcSEcCtD
Etonogestrel—Convulsion—Vincristine—colon cancer	0.00188	0.0027	CcSEcCtD
Etonogestrel—Hypertension—Vincristine—colon cancer	0.00188	0.00269	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00186	0.00982	CbGpPWpGaD
Etonogestrel—Myalgia—Vincristine—colon cancer	0.00185	0.00265	CcSEcCtD
Etonogestrel—Weight increased—Capecitabine—colon cancer	0.00185	0.00265	CcSEcCtD
Etonogestrel—Visual disturbance—Methotrexate—colon cancer	0.00185	0.00264	CcSEcCtD
Etonogestrel—Cough—Irinotecan—colon cancer	0.00185	0.00264	CcSEcCtD
Etonogestrel—Weight decreased—Capecitabine—colon cancer	0.00184	0.00263	CcSEcCtD
Etonogestrel—Hypertension—Irinotecan—colon cancer	0.00183	0.00262	CcSEcCtD
Etonogestrel—Infestation NOS—Capecitabine—colon cancer	0.00181	0.00259	CcSEcCtD
Etonogestrel—Infestation—Capecitabine—colon cancer	0.00181	0.00259	CcSEcCtD
Etonogestrel—Depression—Capecitabine—colon cancer	0.00181	0.00259	CcSEcCtD
Etonogestrel—Discomfort—Irinotecan—colon cancer	0.00178	0.00255	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Capecitabine—colon cancer	0.00178	0.00254	CcSEcCtD
Etonogestrel—Oedema—Vincristine—colon cancer	0.00177	0.00254	CcSEcCtD
Etonogestrel—Anaphylactic shock—Vincristine—colon cancer	0.00177	0.00254	CcSEcCtD
Etonogestrel—Infection—Vincristine—colon cancer	0.00176	0.00252	CcSEcCtD
Etonogestrel—Urinary tract infection—Capecitabine—colon cancer	0.00176	0.00252	CcSEcCtD
Etonogestrel—Convulsion—Fluorouracil—colon cancer	0.00176	0.00251	CcSEcCtD
Etonogestrel—Nervous system disorder—Vincristine—colon cancer	0.00174	0.00249	CcSEcCtD
Etonogestrel—Oedema—Irinotecan—colon cancer	0.00173	0.00247	CcSEcCtD
Etonogestrel—Anaphylactic shock—Irinotecan—colon cancer	0.00173	0.00247	CcSEcCtD
Etonogestrel—Myalgia—Fluorouracil—colon cancer	0.00172	0.00247	CcSEcCtD
Etonogestrel—Infection—Irinotecan—colon cancer	0.00172	0.00246	CcSEcCtD
Etonogestrel—Discomfort—Fluorouracil—colon cancer	0.0017	0.00244	CcSEcCtD
Etonogestrel—Nervous system disorder—Irinotecan—colon cancer	0.00169	0.00242	CcSEcCtD
Etonogestrel—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.00169	0.00892	CbGpPWpGaD
Etonogestrel—CYP3A4—liver—colon cancer	0.00169	0.0151	CbGeAlD
Etonogestrel—Anorexia—Vincristine—colon cancer	0.00169	0.00242	CcSEcCtD
Etonogestrel—Irritability—Methotrexate—colon cancer	0.00167	0.00239	CcSEcCtD
Etonogestrel—Mood swings—Methotrexate—colon cancer	0.00166	0.00237	CcSEcCtD
Etonogestrel—Oedema—Fluorouracil—colon cancer	0.00165	0.00237	CcSEcCtD
Etonogestrel—Anaphylactic shock—Fluorouracil—colon cancer	0.00165	0.00237	CcSEcCtD
Etonogestrel—Anorexia—Irinotecan—colon cancer	0.00165	0.00236	CcSEcCtD
Etonogestrel—Infection—Fluorouracil—colon cancer	0.00164	0.00235	CcSEcCtD
Etonogestrel—Haemoglobin—Capecitabine—colon cancer	0.00163	0.00234	CcSEcCtD
Etonogestrel—Rhinitis—Capecitabine—colon cancer	0.00163	0.00233	CcSEcCtD
Etonogestrel—Haemorrhage—Capecitabine—colon cancer	0.00163	0.00233	CcSEcCtD
Etonogestrel—Nervous system disorder—Fluorouracil—colon cancer	0.00162	0.00232	CcSEcCtD
Etonogestrel—Hypoaesthesia—Capecitabine—colon cancer	0.00162	0.00232	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Vincristine—colon cancer	0.00162	0.00231	CcSEcCtD
Etonogestrel—Pharyngitis—Capecitabine—colon cancer	0.00161	0.00231	CcSEcCtD
Etonogestrel—Urinary tract disorder—Capecitabine—colon cancer	0.00161	0.0023	CcSEcCtD
Etonogestrel—Insomnia—Vincristine—colon cancer	0.0016	0.0023	CcSEcCtD
Etonogestrel—Connective tissue disorder—Capecitabine—colon cancer	0.0016	0.00229	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—colon cancer	0.00159	0.0084	CbGpPWpGaD
Etonogestrel—Urethral disorder—Capecitabine—colon cancer	0.00159	0.00228	CcSEcCtD
Etonogestrel—Paraesthesia—Vincristine—colon cancer	0.00159	0.00228	CcSEcCtD
Etonogestrel—Breast disorder—Methotrexate—colon cancer	0.00158	0.00226	CcSEcCtD
Etonogestrel—Anorexia—Fluorouracil—colon cancer	0.00158	0.00226	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—BCL2L1—colon cancer	0.00158	0.0083	CbGpPWpGaD
Etonogestrel—Visual impairment—Capecitabine—colon cancer	0.00157	0.00224	CcSEcCtD
Etonogestrel—Insomnia—Irinotecan—colon cancer	0.00156	0.00224	CcSEcCtD
Etonogestrel—Paraesthesia—Irinotecan—colon cancer	0.00155	0.00222	CcSEcCtD
Etonogestrel—Decreased appetite—Vincristine—colon cancer	0.00154	0.00221	CcSEcCtD
Etonogestrel—Somnolence—Irinotecan—colon cancer	0.00153	0.0022	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Vincristine—colon cancer	0.00153	0.00219	CcSEcCtD
Etonogestrel—Fatigue—Vincristine—colon cancer	0.00153	0.00219	CcSEcCtD
Etonogestrel—Eye disorder—Capecitabine—colon cancer	0.00152	0.00218	CcSEcCtD
Etonogestrel—Dyspepsia—Irinotecan—colon cancer	0.00152	0.00218	CcSEcCtD
Etonogestrel—Pain—Vincristine—colon cancer	0.00152	0.00217	CcSEcCtD
Etonogestrel—Constipation—Vincristine—colon cancer	0.00152	0.00217	CcSEcCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	0.00151	0.00798	CbGpPWpGaD
Etonogestrel—Asthma—Methotrexate—colon cancer	0.00151	0.00217	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.00151	0.00797	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00151	0.00216	CcSEcCtD
Etonogestrel—Decreased appetite—Irinotecan—colon cancer	0.0015	0.00215	CcSEcCtD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.0015	0.0079	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—BAX—colon cancer	0.0015	0.00789	CbGpPWpGaD
Etonogestrel—Insomnia—Fluorouracil—colon cancer	0.0015	0.00214	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Irinotecan—colon cancer	0.00149	0.00213	CcSEcCtD
Etonogestrel—Fatigue—Irinotecan—colon cancer	0.00149	0.00213	CcSEcCtD
Etonogestrel—Paraesthesia—Fluorouracil—colon cancer	0.00148	0.00213	CcSEcCtD
Etonogestrel—Pain—Irinotecan—colon cancer	0.00148	0.00211	CcSEcCtD
Etonogestrel—Constipation—Irinotecan—colon cancer	0.00148	0.00211	CcSEcCtD
Etonogestrel—Angiopathy—Capecitabine—colon cancer	0.00148	0.00211	CcSEcCtD
Etonogestrel—Somnolence—Fluorouracil—colon cancer	0.00147	0.00211	CcSEcCtD
Etonogestrel—Immune system disorder—Capecitabine—colon cancer	0.00147	0.0021	CcSEcCtD
Etonogestrel—Dyspepsia—Fluorouracil—colon cancer	0.00146	0.00208	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Vincristine—colon cancer	0.00145	0.00208	CcSEcCtD
Etonogestrel—Decreased appetite—Fluorouracil—colon cancer	0.00144	0.00206	CcSEcCtD
Etonogestrel—Alopecia—Capecitabine—colon cancer	0.00144	0.00206	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00143	0.00204	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00143	0.00752	CbGpPWpGaD
Etonogestrel—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.00142	0.00751	CbGpPWpGaD
Etonogestrel—Mental disorder—Capecitabine—colon cancer	0.00142	0.00204	CcSEcCtD
Etonogestrel—Feeling abnormal—Irinotecan—colon cancer	0.00142	0.00204	CcSEcCtD
Etonogestrel—Erythema—Capecitabine—colon cancer	0.00142	0.00203	CcSEcCtD
Etonogestrel—Malnutrition—Capecitabine—colon cancer	0.00142	0.00203	CcSEcCtD
Etonogestrel—Dysuria—Methotrexate—colon cancer	0.00141	0.00203	CcSEcCtD
Etonogestrel—Pain—Fluorouracil—colon cancer	0.00141	0.00202	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Irinotecan—colon cancer	0.00141	0.00202	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Methotrexate—colon cancer	0.00141	0.00201	CcSEcCtD
Etonogestrel—Abdominal pain—Vincristine—colon cancer	0.0014	0.00201	CcSEcCtD
Etonogestrel—Body temperature increased—Vincristine—colon cancer	0.0014	0.00201	CcSEcCtD
Etonogestrel—Flatulence—Capecitabine—colon cancer	0.0014	0.002	CcSEcCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	0.00139	0.00735	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen signaling pathway—PIK3CA—colon cancer	0.00137	0.00723	CbGpPWpGaD
Etonogestrel—Back pain—Capecitabine—colon cancer	0.00137	0.00196	CcSEcCtD
Etonogestrel—Body temperature increased—Irinotecan—colon cancer	0.00136	0.00195	CcSEcCtD
Etonogestrel—Abdominal pain—Irinotecan—colon cancer	0.00136	0.00195	CcSEcCtD
Etonogestrel—Feeling abnormal—Fluorouracil—colon cancer	0.00136	0.00195	CcSEcCtD
Etonogestrel—Muscle spasms—Capecitabine—colon cancer	0.00136	0.00195	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—colon cancer	0.00135	0.00193	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—colon cancer	0.00135	0.00193	CcSEcCtD
Etonogestrel—Depression—Methotrexate—colon cancer	0.00134	0.00193	CcSEcCtD
Etonogestrel—Ill-defined disorder—Capecitabine—colon cancer	0.00131	0.00188	CcSEcCtD
Etonogestrel—Urticaria—Fluorouracil—colon cancer	0.00131	0.00188	CcSEcCtD
Etonogestrel—Body temperature increased—Fluorouracil—colon cancer	0.00131	0.00187	CcSEcCtD
Etonogestrel—Hypersensitivity—Vincristine—colon cancer	0.00131	0.00187	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—BCL2L1—colon cancer	0.0013	0.00685	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.00128	0.00675	CbGpPWpGaD
Etonogestrel—Malaise—Capecitabine—colon cancer	0.00128	0.00183	CcSEcCtD
Etonogestrel—Hypersensitivity—Irinotecan—colon cancer	0.00127	0.00182	CcSEcCtD
Etonogestrel—Asthenia—Vincristine—colon cancer	0.00127	0.00182	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—CCND1—colon cancer	0.00125	0.00656	CbGpPWpGaD
Etonogestrel—Asthenia—Irinotecan—colon cancer	0.00124	0.00177	CcSEcCtD
Etonogestrel—Cough—Capecitabine—colon cancer	0.00124	0.00177	CcSEcCtD
Etonogestrel—Hypertension—Capecitabine—colon cancer	0.00122	0.00175	CcSEcCtD
Etonogestrel—Hypersensitivity—Fluorouracil—colon cancer	0.00122	0.00174	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—colon cancer	0.00122	0.00174	CcSEcCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.00121	0.0064	CbGpPWpGaD
Etonogestrel—Diarrhoea—Vincristine—colon cancer	0.00121	0.00174	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—colon cancer	0.00121	0.00173	CcSEcCtD
Etonogestrel—Myalgia—Capecitabine—colon cancer	0.00121	0.00173	CcSEcCtD
Etonogestrel—Arthralgia—Capecitabine—colon cancer	0.00121	0.00173	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—FGFR3—colon cancer	0.0012	0.00634	CbGpPWpGaD
Etonogestrel—Pharyngitis—Methotrexate—colon cancer	0.0012	0.00172	CcSEcCtD
Etonogestrel—Anxiety—Capecitabine—colon cancer	0.0012	0.00172	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.0012	0.00633	CbGpPWpGaD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.0012	0.00171	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—colon cancer	0.0012	0.00171	CcSEcCtD
Etonogestrel—Discomfort—Capecitabine—colon cancer	0.00119	0.00171	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—colon cancer	0.00119	0.0017	CcSEcCtD
Etonogestrel—Diarrhoea—Irinotecan—colon cancer	0.00118	0.00169	CcSEcCtD
Etonogestrel—Dizziness—Vincristine—colon cancer	0.00117	0.00168	CcSEcCtD
Etonogestrel—Pruritus—Fluorouracil—colon cancer	0.00117	0.00168	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—colon cancer	0.00117	0.00167	CcSEcCtD
Etonogestrel—Oedema—Capecitabine—colon cancer	0.00116	0.00165	CcSEcCtD
Etonogestrel—Infection—Capecitabine—colon cancer	0.00115	0.00164	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—EP300—colon cancer	0.00115	0.00604	CbGpPWpGaD
Etonogestrel—Dizziness—Irinotecan—colon cancer	0.00114	0.00163	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—SRC—colon cancer	0.00114	0.00599	CbGpPWpGaD
Etonogestrel—Nervous system disorder—Capecitabine—colon cancer	0.00113	0.00162	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—colon cancer	0.00113	0.00162	CcSEcCtD
Etonogestrel—Diarrhoea—Fluorouracil—colon cancer	0.00113	0.00162	CcSEcCtD
Etonogestrel—Vomiting—Vincristine—colon cancer	0.00113	0.00161	CcSEcCtD
Etonogestrel—Skin disorder—Capecitabine—colon cancer	0.00112	0.00161	CcSEcCtD
Etonogestrel—ESR1—Estrogen signaling pathway—AKT1—colon cancer	0.00112	0.00591	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.00112	0.0059	CbGpPWpGaD
Etonogestrel—Rash—Vincristine—colon cancer	0.00112	0.0016	CcSEcCtD
Etonogestrel—Dermatitis—Vincristine—colon cancer	0.00112	0.0016	CcSEcCtD
Etonogestrel—Headache—Vincristine—colon cancer	0.00111	0.00159	CcSEcCtD
Etonogestrel—ESR1—FOXA1 transcription factor network—EP300—colon cancer	0.0011	0.00582	CbGpPWpGaD
Etonogestrel—Anorexia—Capecitabine—colon cancer	0.0011	0.00158	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—colon cancer	0.0011	0.00157	CcSEcCtD
Etonogestrel—Vomiting—Irinotecan—colon cancer	0.0011	0.00157	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—colon cancer	0.00109	0.00157	CcSEcCtD
Etonogestrel—Dizziness—Fluorouracil—colon cancer	0.00109	0.00157	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—NRAS—colon cancer	0.00109	0.00576	CbGpPWpGaD
Etonogestrel—Rash—Irinotecan—colon cancer	0.00109	0.00156	CcSEcCtD
Etonogestrel—Dermatitis—Irinotecan—colon cancer	0.00109	0.00156	CcSEcCtD
Etonogestrel—Headache—Irinotecan—colon cancer	0.00108	0.00155	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—colon cancer	0.00107	0.00153	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.00107	0.00562	CbGpPWpGaD
Etonogestrel—Mental disorder—Methotrexate—colon cancer	0.00106	0.00152	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—colon cancer	0.00105	0.00151	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—colon cancer	0.00105	0.00151	CcSEcCtD
Etonogestrel—Nausea—Vincristine—colon cancer	0.00105	0.00151	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00105	0.00151	CcSEcCtD
Etonogestrel—Vomiting—Fluorouracil—colon cancer	0.00105	0.00151	CcSEcCtD
Etonogestrel—Insomnia—Capecitabine—colon cancer	0.00105	0.0015	CcSEcCtD
Etonogestrel—Rash—Fluorouracil—colon cancer	0.00104	0.00149	CcSEcCtD
Etonogestrel—Dermatitis—Fluorouracil—colon cancer	0.00104	0.00149	CcSEcCtD
Etonogestrel—Paraesthesia—Capecitabine—colon cancer	0.00104	0.00149	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.00104	0.00546	CbGpPWpGaD
Etonogestrel—Headache—Fluorouracil—colon cancer	0.00104	0.00148	CcSEcCtD
Etonogestrel—Nausea—Irinotecan—colon cancer	0.00103	0.00147	CcSEcCtD
Etonogestrel—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00102	0.00538	CbGpPWpGaD
Etonogestrel—Back pain—Methotrexate—colon cancer	0.00102	0.00146	CcSEcCtD
Etonogestrel—Dyspepsia—Capecitabine—colon cancer	0.00102	0.00146	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—HNF4A—colon cancer	0.00102	0.00536	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.00101	0.00532	CbGpPWpGaD
Etonogestrel—Decreased appetite—Capecitabine—colon cancer	0.001	0.00144	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—MYC—colon cancer	0.000999	0.00526	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Capecitabine—colon cancer	0.000998	0.00143	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000997	0.00525	CbGpPWpGaD
Etonogestrel—Fatigue—Capecitabine—colon cancer	0.000996	0.00143	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000992	0.00523	CbGpPWpGaD
Etonogestrel—Pain—Capecitabine—colon cancer	0.000988	0.00141	CcSEcCtD
Etonogestrel—Constipation—Capecitabine—colon cancer	0.000988	0.00141	CcSEcCtD
Etonogestrel—Nausea—Fluorouracil—colon cancer	0.000982	0.00141	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—MYC—colon cancer	0.00098	0.00516	CbGpPWpGaD
Etonogestrel—Ill-defined disorder—Methotrexate—colon cancer	0.000978	0.0014	CcSEcCtD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000972	0.00512	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00096	0.00506	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Capecitabine—colon cancer	0.000952	0.00136	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—colon cancer	0.00095	0.00136	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.000949	0.005	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CCND1—colon cancer	0.000949	0.005	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Capecitabine—colon cancer	0.000945	0.00135	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—KRAS—colon cancer	0.000941	0.00496	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000929	0.00489	CbGpPWpGaD
Etonogestrel—Cough—Methotrexate—colon cancer	0.00092	0.00132	CcSEcCtD
Etonogestrel—Urticaria—Capecitabine—colon cancer	0.000918	0.00131	CcSEcCtD
Etonogestrel—Abdominal pain—Capecitabine—colon cancer	0.000913	0.00131	CcSEcCtD
Etonogestrel—Body temperature increased—Capecitabine—colon cancer	0.000913	0.00131	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—colon cancer	0.000913	0.00131	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000908	0.00479	CbGpPWpGaD
Etonogestrel—Myalgia—Methotrexate—colon cancer	0.000897	0.00128	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—colon cancer	0.000897	0.00128	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000891	0.00128	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	0.000889	0.00468	CbGpPWpGaD
Etonogestrel—Discomfort—Methotrexate—colon cancer	0.000887	0.00127	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—EP300—colon cancer	0.000873	0.0046	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—colon cancer	0.000864	0.00455	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Methotrexate—colon cancer	0.00086	0.00123	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000858	0.00452	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000856	0.00451	CbGpPWpGaD
Etonogestrel—Infection—Methotrexate—colon cancer	0.000855	0.00122	CcSEcCtD
Etonogestrel—Hypersensitivity—Capecitabine—colon cancer	0.000851	0.00122	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—CCND1—colon cancer	0.000847	0.00446	CbGpPWpGaD
Etonogestrel—Nervous system disorder—Methotrexate—colon cancer	0.000844	0.00121	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—colon cancer	0.000836	0.0012	CcSEcCtD
Etonogestrel—Asthenia—Capecitabine—colon cancer	0.000829	0.00119	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CCND1—colon cancer	0.000827	0.00436	CbGpPWpGaD
Etonogestrel—Anorexia—Methotrexate—colon cancer	0.00082	0.00117	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CTNNB1—colon cancer	0.000819	0.00432	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	0.000818	0.00431	CbGpPWpGaD
Etonogestrel—Pruritus—Capecitabine—colon cancer	0.000818	0.00117	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—TP53—colon cancer	0.000805	0.00424	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—colon cancer	0.0008	0.00421	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DLC1—colon cancer	0.000799	0.00421	CbGpPWpGaD
Etonogestrel—Diarrhoea—Capecitabine—colon cancer	0.000791	0.00113	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000784	0.00112	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—CCND1—colon cancer	0.000783	0.00413	CbGpPWpGaD
Etonogestrel—Insomnia—Methotrexate—colon cancer	0.000778	0.00111	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—colon cancer	0.000772	0.00111	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—colon cancer	0.000765	0.0011	CcSEcCtD
Etonogestrel—Dizziness—Capecitabine—colon cancer	0.000764	0.00109	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—EP300—colon cancer	0.000762	0.00401	CbGpPWpGaD
Etonogestrel—Dyspepsia—Methotrexate—colon cancer	0.000757	0.00108	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—LGR5—colon cancer	0.000752	0.00396	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00075	0.00395	CbGpPWpGaD
Etonogestrel—Decreased appetite—Methotrexate—colon cancer	0.000748	0.00107	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—colon cancer	0.000743	0.00106	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—colon cancer	0.000742	0.00106	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000736	0.00388	CbGpPWpGaD
Etonogestrel—Pain—Methotrexate—colon cancer	0.000736	0.00105	CcSEcCtD
Etonogestrel—Vomiting—Capecitabine—colon cancer	0.000735	0.00105	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—CDKN1A—colon cancer	0.000733	0.00387	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000729	0.00384	CbGpPWpGaD
Etonogestrel—Rash—Capecitabine—colon cancer	0.000729	0.00104	CcSEcCtD
Etonogestrel—Dermatitis—Capecitabine—colon cancer	0.000728	0.00104	CcSEcCtD
Etonogestrel—Headache—Capecitabine—colon cancer	0.000724	0.00104	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.000713	0.00376	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000712	0.00375	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000709	0.00374	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Methotrexate—colon cancer	0.000709	0.00102	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—FGFR3—colon cancer	0.000707	0.00372	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—colon cancer	0.000706	0.00372	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Methotrexate—colon cancer	0.000703	0.00101	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—SRC—colon cancer	0.000701	0.00369	CbGpPWpGaD
Etonogestrel—Nausea—Capecitabine—colon cancer	0.000686	0.000983	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—colon cancer	0.000683	0.000979	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—colon cancer	0.00068	0.000974	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—colon cancer	0.00068	0.000974	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—colon cancer	0.000679	0.00358	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000678	0.00357	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—TGFB1—colon cancer	0.000678	0.00357	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000676	0.00356	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—EGFR—colon cancer	0.000664	0.0035	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—colon cancer	0.000664	0.0035	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TGFB1—colon cancer	0.000662	0.00349	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—NRAS—colon cancer	0.000653	0.00344	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Methotrexate—colon cancer	0.000634	0.000908	CcSEcCtD
Etonogestrel—Asthenia—Methotrexate—colon cancer	0.000617	0.000884	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000613	0.00323	CbGpPWpGaD
Etonogestrel—Pruritus—Methotrexate—colon cancer	0.000609	0.000871	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.0006	0.00316	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	0.000597	0.00314	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—colon cancer	0.000595	0.00313	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000591	0.00311	CbGpPWpGaD
Etonogestrel—Diarrhoea—Methotrexate—colon cancer	0.000589	0.000843	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—colon cancer	0.000569	0.000815	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—KRAS—colon cancer	0.000562	0.00296	CbGpPWpGaD
Etonogestrel—Vomiting—Methotrexate—colon cancer	0.000547	0.000783	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—colon cancer	0.000545	0.00287	CbGpPWpGaD
Etonogestrel—Rash—Methotrexate—colon cancer	0.000542	0.000777	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—colon cancer	0.000542	0.000776	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00054	0.00285	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AXIN2—colon cancer	0.00054	0.00285	CbGpPWpGaD
Etonogestrel—Headache—Methotrexate—colon cancer	0.000539	0.000772	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—PIK3CA—colon cancer	0.000516	0.00272	CbGpPWpGaD
Etonogestrel—Nausea—Methotrexate—colon cancer	0.000511	0.000732	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—HRAS—colon cancer	0.000493	0.0026	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HNF4A—colon cancer	0.000489	0.00258	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—HRAS—colon cancer	0.000478	0.00252	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—AKT1—colon cancer	0.000471	0.00248	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DLC1—colon cancer	0.000469	0.00247	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.00046	0.00242	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000447	0.00236	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000443	0.00233	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—PPARG—colon cancer	0.000441	0.00233	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LGR5—colon cancer	0.000441	0.00232	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—AKT1—colon cancer	0.000436	0.0023	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	0.00043	0.00227	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—AKT1—colon cancer	0.000422	0.00222	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000412	0.00217	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00041	0.00216	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.00041	0.00216	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.00039	0.00206	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—NRAS—colon cancer	0.000383	0.00202	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000381	0.00201	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000371	0.00195	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000367	0.00193	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000359	0.00189	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000359	0.00189	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000351	0.00185	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—colon cancer	0.000349	0.00184	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000341	0.0018	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000332	0.00175	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000332	0.00175	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—colon cancer	0.00033	0.00174	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000323	0.0017	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AXIN2—colon cancer	0.000317	0.00167	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	0.000303	0.0016	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000297	0.00157	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000297	0.00156	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000295	0.00155	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000291	0.00153	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HNF4A—colon cancer	0.000287	0.00151	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA7—colon cancer	0.000284	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—colon cancer	0.00028	0.00148	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000275	0.00145	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—colon cancer	0.000259	0.00137	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000252	0.00133	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—colon cancer	0.000252	0.00133	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000249	0.00131	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—colon cancer	0.000248	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000244	0.00129	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—colon cancer	0.000213	0.00112	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000206	0.00109	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CHST5—colon cancer	0.000172	0.000906	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ODC1—colon cancer	0.000172	0.000906	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGFR3—colon cancer	0.000156	0.000822	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—colon cancer	0.000148	0.000778	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APC—colon cancer	0.000143	0.000754	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BRAF—colon cancer	0.000135	0.000709	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—colon cancer	0.000125	0.000657	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—colon cancer	0.000121	0.000638	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—colon cancer	0.000101	0.000532	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—colon cancer	9.82e-05	0.000518	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNB1—colon cancer	9.73e-05	0.000512	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1A—colon cancer	9.5e-05	0.000501	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGFR3—colon cancer	9.15e-05	0.000482	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EP300—colon cancer	9.04e-05	0.000476	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SRC—colon cancer	8.79e-05	0.000463	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—colon cancer	8.56e-05	0.000451	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRAS—colon cancer	8.46e-05	0.000446	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APC—colon cancer	8.4e-05	0.000443	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—colon cancer	8.4e-05	0.000443	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BRAF—colon cancer	7.9e-05	0.000416	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—colon cancer	7.88e-05	0.000415	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—colon cancer	7.86e-05	0.000414	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—colon cancer	7.71e-05	0.000406	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—colon cancer	7.28e-05	0.000384	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—colon cancer	7.11e-05	0.000375	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—colon cancer	6.69e-05	0.000352	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—colon cancer	6.47e-05	0.000341	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—colon cancer	6.19e-05	0.000326	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—colon cancer	5.92e-05	0.000312	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—colon cancer	5.76e-05	0.000304	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNB1—colon cancer	5.71e-05	0.000301	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1A—colon cancer	5.58e-05	0.000294	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—colon cancer	5.46e-05	0.000288	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EP300—colon cancer	5.31e-05	0.00028	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SRC—colon cancer	5.16e-05	0.000272	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—colon cancer	5.03e-05	0.000265	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRAS—colon cancer	4.96e-05	0.000262	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—colon cancer	4.93e-05	0.00026	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—colon cancer	4.62e-05	0.000244	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—colon cancer	4.61e-05	0.000243	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCB1—colon cancer	4.54e-05	0.000239	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—colon cancer	4.52e-05	0.000238	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TYMS—colon cancer	4.46e-05	0.000235	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—colon cancer	4.27e-05	0.000225	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—colon cancer	3.92e-05	0.000207	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—colon cancer	3.8e-05	0.0002	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—colon cancer	3.63e-05	0.000191	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—colon cancer	3.21e-05	0.000169	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—colon cancer	3.16e-05	0.000167	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—colon cancer	2.49e-05	0.000131	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—EP300—colon cancer	2.07e-05	0.000109	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—colon cancer	1.53e-05	8.06e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—colon cancer	1.25e-05	6.59e-05	CbGpPWpGaD
